{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-21-007247","form_type":"8-K","ticker":"UEEC","cik":"0001096938","company_name":"United Health Products, Inc.","filed_at":"2021-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.479406+00:00","generated_at":"2026-06-28T20:45:58.637373+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"United Health Products updates on FDA PMA process and Triton Funds investment","bullets":["FDA requested details on HemoStyp manufacturing process; UHP implemented GMP software tool and will respond later this month.","SEC declared UHP's registration statement effective on September 29, allowing closure of $4M-$6M stock purchase with Triton Funds.","UHP produced a prototype of new HemoStyp format for trauma/surgical applications; further testing planned.","Company will host investor information session on October 15, 2021 at 9am ET."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-21-007247","json":"https://secwatch.observer/filing/0001477932-21-007247.json","markdown":"https://secwatch.observer/filing/0001477932-21-007247.md","text":"https://secwatch.observer/filing/0001477932-21-007247.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1096938/000147793221007247/0001477932-21-007247-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1096938/000147793221007247/ueec_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:45:58.637373+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}